An observational study in Violence Against Women (VAW), sponsored by L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-18.
Sponsored by L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This single-center observational study aims to assess the feasibility of systematically screening for intimate partner violence (IPV) against women in the emergency department of Hôpital Nord-Ouest de Villefranche-sur-Saône. The study utilizes the Woman Abuse Screening Tool (WAST), a self-administered questionnaire, to identify cases of IPV. The primary objective is to evaluate the feasibility and acceptability of implementing this systematic screening within an emergency setting. The study will measure feasibility through factors such as the implementation rate and adherence by healthcare staff, while acceptability will be assessed based on patient participation and response rates. By analyzing these criteria, the study seeks to determine whether IPV screening can be effectively integrated into routine emergency care. The findings are expected to provide insights into potential barriers and facilitators for screening implementation, contributing to improved detection and support strategies for women experiencing domestic violence.
L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult female patients presenting spontaneously to the Emergency Department of Villefranche-sur-Saône Hospital who meet all inclusion criteria and none of the exclusion criteria. The required sample size is estimated at 101 participants.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Self-questionnaire completed in the waiting room of the emergency department, either on paper or online by scanning a QR-code
Feasibility of systematic screening using WAST
Assessed by the proportion of eligible women screened with WAST.
Time frame: At the time of outpatient consultation (Day 0)
Acceptability of WAST
Assessed using an acceptability questionnaire completed by healthcare patient
Time frame: At the time of outpatient consultation (Day 0)
Ran from Apr 2025 to primary completion in Jun 2025, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône